focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
@rivaldo I think you're right! If you look at the 2 x 50,000 buys yesterday lunchtime, that was me trying to buy 100,000 and being denied. I'm not going to make insane predictions (£1 by Xmas, etc!), but I can see this share returning to pre=profit warning levels of 16p by early 2021.
I'm confident that the Government will resort to big infrastructure projects to kick-start the economy (and hopefully re-employ many of those who have lost their jobs recently) - it's the classic response to a recession. And they don't get much bigger than rail projects! Consider that this will be mirrored across the world, and Petards could be in for a lot of large contracts.
I think this rise is simply a bounce-back from the incredibly low prices of a few weeks ago. Also, prices often rise in the weeks before annual report and accounts - Petards are due to report on 2017 in mid-March. And last week's MOD news means that their figures for this year are likely to be very strong. Bear in mind that Petards are still very cheap compared to other specialist engineering/software companies - so without any more big announcements I'd expect this to continue to rise about 30p in the very near future
Petards finally have a proper website - far more professional and appropriate for them. More important, they're currently advertising 4 roles - all of them in engineering and software. http://www.petards.com/careers-and-jobs/ This feels like a company gearing up for significant growth
Like many, I'm frustrated at the price - being dependent on a steady stream of big orders is a real problem. But.. https://www.theguardian.com/business/2017/jun/20/bombardier-wins-900m-south-west-trains-deal Any thoughts?
It looks like their bid is in http://www.itv.com/news/tyne-tees/2017-01-20/hitachi-bids-for-2-75bn-hs2-contract-to-build-trains-in-north-east/
Hi Thanks - it looks like some of these loan notes have already been redeemed (by the directors) but i'm not sure how many. This would mean that there's already been a bit of dilution - any idea how much? D
Hi I've also watched this grow insanely over the last few months. However, I wonder if it's really overvalued, or even fairly valued yet. The P/E is still around 15, which is really nothing special - and is based on last year's results. P/Es in this sector can comfortably run at 30 or more. Not saying you're wrong here - your posts are always worth reading - but I'd be interested in your thinking
Here's a strange coincidence. The founder of ToHealth is Tuvi Orbach - who's also the founder of Ultrasis.
Hi The press release is quite odd: it talks about 14 new customer groups, not customers. This doesn't sound like they've suddenly won a load of new business, more like they're talking with a lot of people, or... Anyone have any idea what this means? With ULT in the UK probably unable to win any business (would you do business from a company who's shares were suspended?) our best hope is for revenue from one of its joint ventures.
I think we're all agreed that ULT is finished as a company (and before anyone accuses me of deramping, I'm stuck with 4 million of these near-worthless shares). However, it strikes me that we could do better from dissolution than the BOD's current plans. My thinking is this. ULT's value lies in the contracts won by Screenetics. These are bringing in real money and the company seems to be focused, successful and well-run (unlike ULT). If ULT closes/goes into liquidation, Screenerics would almost certainly keep going as a standalone business, or maybe be sold to a larger group. Either way, it's possible that this would bring in more money than the pennies we're likely to get otherwise. Don't get me wrong: no-one's going to get rich here, but thus may be the least-worst option. Any thoughts?
Has anyone else noticed that for all the noise around Beating The Blues, almost all of Ultrasis's revenue is coming from Screenetics? It seems that while we get one 'jam tomorrow' message after another from ULT, its Screenetics division is generating a lot of revenue; better still, it's tapping into the Public Sector, which tends to be very conservative - now they've got one major public sector contract, others are pretty much guaranteed to follow. Anyone else wonder how much longer ULT will continue promoting BTB - if Screenetics is making all the money, wouldn't it make sense for ULT to put all its energies into this part of its business?